Year: 2022

LIKE THE PHARMA industry market dynamics, this is akin to an innovator brand drug loosing the patent and opening the gate for cheaper generics. The Myriad court decision triggered the emergence of cheaper competitive tests. View in LinkedIn

FLORID ALZHEIMER'S is too late stage and screwed up to have serious hope of a treatment; going downstream to MCI is a better strategy. View in LinkedIn

BIOSIMILAR PERSPECTIVE. Interesting read. http://lnkd.in/gWxEJw View in LinkedIn

THE ROI on the Human Genome Project is claimed to be 60X. Even if it were one tenth of that, it would beat the socks off the average VC return. Count in jobs as an intangible, and it is hard to see how societies would not line up to repeat such an experiment. Add in how this project has been a Game Changer in medicine, and started a whole new paradigm shift to preventative medicine. We have not begun to count those savings. Frame this article on your wall as a reminder of a huge success story. http://mobile.bloomberg.com/news/2013-06-12/human-genome-project-spurred-966-billion-sciences-boom.html View in LinkedIn

COMPULSORY LICENSES in China and India are evolving, but appear to be following the path of making a drug innovator grant patent licenses to generic drug makers. How this plays out will cast the landscape for pharmaceutical markets for 2.5 billion consumers in a planet of 7 billion. http://www.millercanfield.com/publications-articles-321.html?goback=.gde_4513133_member_249734556 View in LinkedIn

COLLABORATIVE ECONOMY STARTUPS raised 2 Bn USDs in VC money. http://www.web-strategist.com/blog/2013/06/14/infographic-collaborative-economy-startups-proliferating/ View in LinkedIn

RICHARD BRANSON is a wildly popular figure. Why is this? Possibly because he is a David and Goliath figure who took on the giant airlines that we all hate with the motto "but we will offer service!" Possibly because he looks anti-establishment, with long hair and a beard, and we can all identify with him. Possibly because he blogs with great simplicity and modesty. Perhaps because he dreams big. Space tourism? Bottom line is this man is a superb communicator and has a giant following. http://lnkd.in/ATUkt8 View in LinkedIn

EUROPE HAS BECOME A LEADER on the world stage, with numerous bold initiatives to overcome a stagnant economy. This improbable status has been earned many times, stimulated out of lethargy by the jolt of the Crisis. Without the Crisis, the status quo would have been paralyzing. Japan has shown similar bold initiatives with doubling the money supply and creating the 22 Bn INCJ VC fund. Not without the jolt of the Crisis. The Crisis for all the personal pain has been invigorating to societies. http://lnkd.in/6FghCU View in LinkedIn

GREEN SOLVENTS are being quietly developed in labs across the world. Old chemistry has been used by giant manufacturing companies for over 100 years, producing toxic pollutants. But the next generation of green solvents that do the same work without the toxic by-products are emerging. We may be there in a decade or two. Great news. http://lnkd.in/WdDCfy View in LinkedIn

DRUG RESISTANCE tends to reside in an organism's variable amino acid outer layer, where mutations of drug and vaccine target are not lethal for the creature. In a past life we spent a lot of time creating vaccine targets against parts of a bug's outer coat that had been conserved in evolution. It had been conserved because mutations in this region were lethal. By looking at the variants of a bug and asking which regions had mutated versus those regions which had not, yielded great targets for vaccine development. We did this for severe tropical childhood diarrhea bugs. http://lnkd.in/dw9EGY View in LinkedIn